Clinical characteristics and prognosis of 44 cases of infantile neuroblastoma
10.3760/cma.issn1008-6706.2022.04.003
- VernacularTitle:婴儿神经母细胞瘤44例临床特点及预后分析
- Author:
Jia HE
1
;
Ying LIU
;
Kang HUANG
;
Dajun FU
;
Shikai CHENG
Author Information
1. 中国医科大学附属第四医院儿科，沈阳 110032
- Keywords:
Neuroblastoma;
Disease attributes;
Prognosis;
Risk factors;
Neoplasm metastasis;
Survival rate;
Infant;
Retrospective studies
- From:
Chinese Journal of Primary Medicine and Pharmacy
2022;29(4):490-494
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical characteristics of infantile neuroblastoma (NB) and the factors that affect prognosis.Methods:We retrospectively analyzed the clinical data collected from 44 cases of NB who received treatment in The Fourth Affiliated Hospital of China Medical University from March 2008 to March 2017 to summarize the clinical characteristics of NB and the factors that affect prognosis.Results:Among the 44 cases, 21 were male and 23 were female, with a median age of 5.5 months (range, 0 days-12 months). Four cases had stage I NB, seven cases stage II NB, five cases stage III NB, 15 cases stage IV NB, and 13 cases stage IVs NB. The tumors were located in the adrenal glands and retroperitoneum ( n = 26, 59.1%), posterior mediastinum ( n = 15, 34.1%), pelvis ( n = 2, 4.5%), and neck ( n = 1, 2.3%). The median follow-up time was 90 months (range, 2-144 months). The 3-year and 5-year overall survival rates were 93.2% and 90.9%, respectively. Among 35 cases who survived more than 5 years, 30 cases survived healthily, 5 cases survived with tumor, and 4 cases died. Bone marrow metastasis, bone metastasis, and the extent of tumor resection greatly affect the prognosis of NB ( χ2 = 6.92, 12.19, 4.70, all P < 0.05). Conclusion:The overall prognosis of NB is good in infants. NB mainly occurs in the abdomen. The survival rate of infants with stage IVs NB is lower than that of infants with stages I, II, and III NB. The prognosis of NB occurring in the abdomen is poorer than that occurring in other regions. Bone marrow metastasis, bone metastasis, and the extent of tumor resection are adverse factors affecting the prognosis.
